Authors:
BACKONJA M
BEYDOUN A
EDWARDS KR
SCHWARTZ SL
FONSECA V
HES M
LAMOREAUX L
GAROFALO E
Citation: M. Backonja et al., GABAPENTIN FOR THE SYMPTOMATIC TREATMENT OF PAINFUL NEUROPATHY IN PATIENTS WITH DIABETES-MELLITUS - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 280(21), 1998, pp. 1831-1836
Authors:
EDWARDS KR
HES MS
LAMOREAUX LK
GAROFALO EA
KOTO EM
Citation: Kr. Edwards et al., GABAPENTIN (NEURONTIN(R)) FOR PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY(945-210), Neurology, 50(4), 1998, pp. 6011-6011
Citation: Dl. Potter et al., AN OPEN-LABEL STUDY OF TACRINE FOR TREATMENT OF RESIDUAL COGNITIVE DEFECTS IN PATIENTS WITH TRAUMATIC BRAIN INJURY, Neurology, 48(3), 1997, pp. 1069-1069
Authors:
CLEELAND CS
NAKAMURA Y
HOWLAND EW
MORGAN NR
EDWARDS KR
BACKONJA M
Citation: Cs. Cleeland et al., EFFECTS OF ORAL MORPHINE ON COLD PRESSOR TOLERANCE TIME AND NEUROPSYCHOLOGICAL PERFORMANCE, Neuropsychopharmacology, 15(3), 1996, pp. 252-262
Authors:
CLEELAND CS
NAKAMURA Y
MENDOZA TR
EDWARDS KR
DOUGLAS J
SERLIN RC
Citation: Cs. Cleeland et al., DIMENSIONS OF THE IMPACT OF CANCER PAIN IN A 4 COUNTRY SAMPLE - NEW INFORMATION FROM MULTIDIMENSIONAL-SCALING, Pain, 67(2-3), 1996, pp. 267-273
Citation: Rc. Serlin et al., WHEN IS CANCER PAIN MILD, MODERATE OR SEVERE - GRADING PAIN SEVERITY BY ITS INTERFERENCE WITH FUNCTION, Pain, 61(2), 1995, pp. 277-284
Authors:
KNAPP MJ
KNOPMAN DS
SOLOMON PR
PENDLEBURY WW
DAVIS CS
GRACON SI
APTER JT
LAZARUS CN
BAKER KE
BARNETT M
BAUMEL B
EISNER LS
CASTELLS B
BOLOURI R
BENNETT D
FORCHETTI C
LEVIN A
BLASS JP
NOLAN KA
GAINES ER
RELKIN N
BORISON RL
DIAMOND B
CELESIA GG
ROSS AP
DEXTER J
DOODY R
LIPSCOMB L
KREITER K
DUBOFF EA
BLOCK P
MARSHALL D
WESTERGAARD N
EARL NL
WYNE SV
HINMANSMITH E
FARLOW M
HENDRIE HC
CARESS JA
FARMER M
HARPER JE
FERGUSON J
FOSTER NL
BARBAS NR
BLUEMLEIN LA
GELB DJ
BERENT S
GIORDANI B
GREENWALD M
BERGMAN S
ROGER LF
GROENENDYK A
WOOD M
JURKOWSKI C
KATZ I
DOYLE S
SMITH BD
KELLNER C
BERNSTEIN HJ
BACHMAN DL
KNOPMAN DS
DEINARD S
LANGLEY L
BRIDGES S
MARGOLIN RA
BURGER MC
WISER SL
CRENSHAW C
MORRIS JC
RUBIN EH
COATS MA
REYES PF
BENTZ C
DOYLE LL
RYMER MM
BETTINGER IE
LAUBINGER MP
SADOWSKY CH
MARTINEZ W
ZUNIGA J
STONE R
WINNER P
MATE L
LESSARD C
SCHNEIDER L
PAWLUCZYK S
SMITH WT
LOSK SN
MARAMBE L
SOLOMON PR
PENDLEBURY WW
GROCCIAELLISON ME
EDWARDS KR
TAYLOR J
CALABRESE VP
HARKINS SW
THEIN SG
DEWAR JA
WILLIAMS G
DRENNAN C
TUTTLE P
PRINCIPI N
FORD EM
TYNDALL RJ
KELLEY CK
Citation: Mj. Knapp et al., A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 985-991
Authors:
SOLOMON PR
GROCCIAELLISON M
FLYNN D
MIRAK J
EDWARDS KR
DUNEHEW A
STANTON ME
Citation: Pr. Solomon et al., DISRUPTION OF HUMAN EYEBLINK CONDITIONING AFTER CENTRAL CHOLINERGIC BLOCKADE WITH SCOPOLAMINE, Behavioral neuroscience, 107(2), 1993, pp. 271-279
Citation: Kr. Edwards et al., INFLUENCES OF ACADEMIC TRAINING AND NONACADEMIC EXPERIENCE ON SUSCEPTIBILITY TO THE HORIZONTAL VERTICAL ILLUSION, Bulletin of the Psychonomic Society, 31(5), 1993, pp. 465-467